Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion type Assertion NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_head.
- NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion wasGeneratedBy ECO_0000203 NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_provenance.
- NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion wasDerivedFrom befree-20140225 NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_provenance.
- NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion SIO_000772 23427296 NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_provenance.
- NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion evidence source_evidence_literature NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_provenance.
- NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_assertion description "[Therefore, ADCs of the humanized anti-CD74 antibody, milatuzumab, were examined for the therapy of CD74-expressing solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598032.RA_jxiVrdm2HDvdkke8z1hxHCxQUkUqd1jrP5yuJlzlYw130_provenance.